Director/PDMR Shareholding
On October 15, 2025, Ije Nwokorie, Chief Executive Officer of Dr. Martens plc, acquired 633,249 ordinary shares following the vesting of restricted stock units granted under the company's Long Term Incentive Plan. Subsequently, 298,675 shares were sold at a price of £0.8967 per share to cover tax and national insurance liabilities. The acquisition of shares occurred outside a trading venue, while the sale of shares took place on XLON. These transactions relate to a portion of an RSU award granted on June 14, 2024, in lieu of forfeited incentive awards from a previous employer, as part of buyout arrangements.
Select text to share a quote on X · sign in to keep highlights & notes in your DOCS notes
- Martens plc (the 'Company') announces that it has been notified of the following transaction(s) in the Company's Ordinary 1p shares undertaken on behalf of a director and person discharging managerial responsibility ('PDMR').
On 15 October 2025, a tranche of restricted stock units ('RSUs') granted to Ije Nwokorie under the Company's Long Term Incentive Plan ('LTIP') prior to his appointment as Chief Executive Officer vested and sufficient shares were subsequently sold on his behalf to cover his consequent tax and national insurance liabilities.
This tranche constitutes a portion of the RSU award which was granted to Ije on 14 June 2024 in lieu of outstanding incentive awards he forfeited on leaving his previous employer (the Award). The Award was made pursuant to the buyout arrangements agreed to secure Ije's recruitment to his previous role as Chief Brand Officer, which he held from February 2024 until he became Chief Executive Officer in January 2025, and in line with the stipulations of the Company's Remuneration Policy that 'buyout awards' be granted on a like-for-like basis to the extent possible. Full details of awards made to Ije under the LTIP will be disclosed in the Directors' Remuneration Report within the FY26 Annual Report, scheduled to be published in June 2026.
The relevant notifications, set out below, are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Ije Nwokorie | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Executive Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Acquisition of shares following vesting of restricted stock units | ||||
| c) | Price(s) and volume(s) | Price(s) Volume(s) Nil 633,249 | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 15 October 2025 | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Ije Nwokorie | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Executive Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 15 October 2025 | ||||
| f) | Place of the transaction | XLON |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.